REAL WORLD OBSERVATIONAL STUDIES IN

CARDIOMETABOLIC MEDICINE

BI-WEEKLY REVIEWS

REGISTER FOR FREE

LATEST REVIEWS

Jan
15
Cardiovascular Benefits of Acarbose vs Sulfonylureas in Patients With Type 2 Diabetes Treated With Metformin.
Pai-Feng Hsu, Shih-Hsien Sung, Hao-Min Cheng, Shyi-Jang Shin, Kun-Der Lin, Keong Chong, Fu-Shun Yen, Ben-Hui Yu, Chi-Ting Huang, Chih-Cheng Hsu,
Dec
04
Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.
Antonios Douros, Sophie Dell'Aniello, Oriana Hoi Yun Yu, Kristian B Filion, Laurent Azoulay, Samy Suissa,
Dec
04
Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes.
Hsien-Yen Chang, Sonal Singh, Omar Mansour, Sheriza Baksh, G Caleb Alexander,
Dec
03
Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population-based, propensity-score-matched cohort study.
Shihchen Kuo, Chun-Ting Yang, Jin-Shang Wu, Huang-Tz Ou,
Nov
22
Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK.
Krishnan Bhaskaran, Isabel Dos-Santos-Silva, David A Leon, Ian J Douglas, Liam Smeeth,

GO TO REVIEWS

BLOG

Jan
15

Author's contribution: Use of sulfonylureas as monotherapy

VIEW

NEWS

Jan
15

Reporting of studies in pharmacoepidemiology (RECORD-PE)

VIEW

EVENTS

No upcoming events.